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Background: The construction of a colostomy is a common procedure, but the evidence for the different parts of
the construction of the colostomy is lacking. Parastomal hernia is a common complication of colostomy formation.
The aim of this study is to standardise the colostomy formation and to compare three types of colostomy
formation (one including a mesh) regarding the development of parastomal hernia.
Methods/Design: Stoma-Const is a Scandinavian randomised trial comparing three types of colostomy formation.
The primary endpoint is parastomal herniation as shown by clinical examination or CT scan within one year.
Secondary endpoints are re-admission rate, postoperative complications (classified according to Clavien-Dindo),
stoma-related complications (registered in the case record form at stoma care nurse follow-up), total length of
hospital stay during 12 months, health-related quality of life and health economic analysis as well as re-operation
rate and mortality within 30 days and 12 months of primary surgery. Follow-up is scheduled at 4-6 weeks, and
6 and 12 months. Inclusion is set at 240 patients.
Discussion: Parastomal hernia is a common complication after colostomy formation. Several studies have been
performed with the aim to reduce the rate of this complication. However, none are fully conclusive and data on
quality of life and health economy are lacking. The aim of this study is to develop new standardised techniques
for colostomy formation and evaluate this with patient reported outcomes as well as clinical and radiological
assessment.
Trial registration: Clinicaltrials.gov, NCT01694238.2012-09-24.
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Colostomy formation has been a standard surgical proced-
ure for more than 100 years. A well-functioning colos-
tomy may not negatively affect the patient’s quality of life
(QoL) [1]; however, this can only be said if the stoma is
well functioning and if complications are kept to a mini-
mum. The complication rates after stoma formation are
considerable, with figures of 21-70% [2,3], and studies
have shown that adequate stoma height, type of stoma,* Correspondence: eva.angenete@vgregion.se
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article, unless otherwise stated.body mass index (BMI), emergency surgery and gender
may be of importance in reducing the risk of complica-
tions in both the short- and long-term perspectives [4-6].
The surgical technique of stoma formation is only
partly evidence based. There are few studies focused on
technical details about stoma construction and their fu-
ture impact on stoma function. One study has attempted
to standardise the skin incision to two-thirds of the
width of the bowel [7], although the actual impact of this
on the functional outcome of the stoma function was
not presented. In the surgical literature a cruciate inci-
sion in the fascia and extraction of the bowel through a
hole sufficient in size is a standard description of the
surgical technique [8]. In clinical practice the sufficientCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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width’, which is a fairly inexact measurement.
Parastomal hernia is a long-term complication that is
common; in the literature figures up to almost 50% have
been reported [9,10]. There have been discussions regard-
ing the placement of the stoma and effects on hernia inci-
dence [11,12]; however, no studies have been sufficient in
design or size to thoroughly answer the question. At-
tempts to reduce the rates of parastomal hernias have
been made in the last few years with the placement of a
mesh at the construction of the stoma [13-18]. However,
these trials did not include studies of health-related QoL
or health economic aspects. The placement of a prophy-
lactic parastomal mesh has not been universally accepted,
mainly due to a hesitance related to the possible risk of in-
fection with a foreign body, but also as most studies were
small in sample size [19]. Another suggestion for the basic
construction of the stoma has been to make a circular in-
stead of a cruciate incision in the fascia, but this has not
been studied. It has been described in conjunction with
the use of circular stapling devices, and no hernias were
found, but the studies were small [20,21]. Thus, it is ap-
parent that further studies are desired [17,22-24] and
several randomised controlled trials are registered and
ongoing.
The evaluation of parastomal hernias can be per-
formed by clinical examination, CT scan or ultrasound
[14,15,25,26]. All techniques have advantages and disad-
vantages, and the conclusion must be that evaluation of
parastomal hernias may be difficult and must be standar-
dised in a study.
The hypothesis to be tested in this study is that it is
possible to obtain a lower incidence of parastomal hernia
with a circular incision in the abdominal fascia or with
reinforcement with a mesh instead of a cruciate incision
in the abdominal fascia.
The study will provide a precise control compared to
the two interventions with thorough measurements of
the bowel and the trephine opening to improve the
evaluation of the surgical technique. It will also enable
an evaluation of QoL and health economy.
Methods
Study objective
The Stoma-Const trial is a randomised trial comparing
three different surgical procedures for the construction
of a colostomy.
Endpoints
The primary endpoint is the presence of parastomal her-
nia as detected by clinical examination or CT scan at
12 months after surgery. A bulge in the vicinity of the
stoma is not sufficient in this study to define a parasto-
mal hernia. If there is any doubt in the clinical setting,the patients must be examined by a CT scan in a prone
position. Secondary endpoints include: re-admission
rate, postoperative complications (classified according
to Clavien-Dindo [27]), stoma-related complications
(registered in the case record form (CRF) at Stoma Care
nurse follow-up), total length of hospital stay during
12 months, health-related quality of life and health eco-
nomic analysis, re-operation rate, mortality within 30 days
and 12 months of primary surgery. Re-admissions and re-
operations as registered in the hospitals’ databases at
24 months to ascertain that possible long-term complica-
tions related to the stoma construction are identified.
Inclusion criteria
Patients are eligible if the following conditions are met:
 the patient is presenting with a condition for which
an elective surgical procedure is planned including
formation of a colostomy
 it is possible to operate on the patient in regard to
concomitant disease
 the patient has given informed consent to participate
Exclusion criteria
 Participation in other randomised trials in conflict with
the protocol and endpoints of the Stoma-Const trial.
External validity
All patients with a condition for which an elective surgical
procedure is planned including a colostomy formation,
and who are not included and randomised, will be regis-
tered in the ‘screening log’ at each participating centre in-
cluding information on date, hospital, gender, age, ASA
classification and type of operation. The reason for non-
inclusion or exclusion is noted.
Randomisation
All participating patients give written informed consent.
After inclusion no changes are made in the planning for
the operation. The patient will be randomised to one of
the three groups of intervention during surgery in the
operating theatre directly prior to the stoma formation
(Figure 1). Randomisation will be performed by blocks
of closed envelope systems in each participating hospital.
It will be balanced and stratified by hospital. Laparo-
scopic as well as open procedures will be included and,
although not stratified by open or laparoscopic proce-
dures, their use will be noted in the CRF.
Including hospitals may choose to randomise between
all three techniques or two of them. This decision is made
before the hospital enters the study. The blocks will be set
up according to this system, and the total number of 80
Figure 1 Consort diagram for the Stoma-Const trial.
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system.
When patients are not subject to the treatment modality
as randomised, data will be analysed on an ‘intention-to-
treat basis’ (once randomised, patients will not be ex-
cluded or change groups because of conversion or type of
surgery). Patients who do not consent to participation or
are excluded will be treated by cross incision in the fascia
as the usual routine.
Surgical procedure
A stoma care nurse marks all stoma sites preoperatively.
At the time of the stoma formation, randomisation to one
of the three (or in applicable cases two) procedures is
made. The centre point of the preoperatively marked place
for the stoma is lifted and a circular skin incision is per-
formed. Blunt or ‘semi-blunt’ dissection is used through
the subcutaneous tissue, using a step-wise downwards
movement with retractors assisted by sharp dissection as
needed. When the ventral fascia of the rectus abdominishas been reached, dissection is stopped. A disposable, ster-
ile measurement tape is used in the open surgical proce-
dures, and the metric scale on the laparoscopic stapler is
used in laparoscopic surgical procedures. The depth of the
subcutaneous fat is measured. The width of the left colon
together with its mesocolon is measured at the point
where it will pass through the fascia (the depth of the sub-
cutaneous fat + 20-30 mm). The fascia incision is calcu-
lated using this measurement - circular incision in the
fascia with a diameter equalling 50% of the width of the
patient’s left colon with mesocolon, or a cruciate incision
where the arms measure one-half of the width of the pa-
tient’s left colon with mesocolon. If it is apparent that the
incision will be too large, it may be reduced, but measured
thoroughly and noted in the operative CRF. The muscular
fibres are separated bluntly.
Stoma formation without a mesh
The dorsal fascia is opened. The proximal colon end is
taken through the stoma incision (plica epiploicae may
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equate circulation to the colon involved in the stoma. If
the width of the incision is insufficient for adequate cir-
culation, a widening should be performed, measured and
noted in the CRF. The muco-cutaneous suturing is made
using 4-0 absorbable interrupted sutures, three-point su-
tures (mucosa, muscular layer and skin) starting with one
in each quadrant and adding ordinary muco-cutaneous
sutures in between as needed. The height of the stoma
after it is created should be at least 1 cm.
Stoma formation with a mesh
The incision in the fascia is performed with a cruciate
incision, with size according to the measurements de-
scribed above, and the mesh will be placed using the
sublay technique as previously described [14]. A fine-
thread, large-pore lightweight polypropylene monofila-
ment mesh measuring 10 × 10 cm is used. The mesh is
placed dorsal to the rectus abdominis muscle and anter-
ior to the posterior rectus fascia by dissection through
either midline in open surgery or by blunt dissection
under the rectus abdominis muscle in laparoscopic sur-
gery. A cruciate incision with a size measured according
to the instructions above is made in the anterior sheath
of the fascia and in the mesh. The bowel is brought out
through a cross-cut in the centre of the mesh where the
arms should measure one-half of the width of the pa-
tient’s left colon and its mesocolon. If the width of the
incision is not sufficient, a widening should be per-
formed, measured and noted in the CRF. Stitches fix the
lateral corners of the mesh to the posterior rectus
sheath. The medial corners of the mesh are grasped with
a stitch of the running suture closing the midline inci-
sion during open surgery, and this is not applicable to
laparoscopic procedures.
The diameter of the stoma is measured immediately
after the operation.
Postoperative treatment
Local guidelines are followed and must be applied equally
in all three (in applicable cases, two) groups, without any
systematic differences. Any postoperative treatment with
antibiotics must be noted in the CRF, including reasons
and total treatment time. This applies to both systemic as
well as oral antibiotics. All postoperative information re-
garding stoma and stoma function will be given according
to local routines.
Follow-up
The follow-up during the postoperative hospital stay is
recorded in a CRF. Time until full oral feeding is re-
sumed and time until first gas and stool are registered.
Patients will be clinically examined at 6 (5–7) months
and at 12 (11–13) months postoperatively and further asneeded (suspected parastomal herniation), by a surgeon
(not one of the colorectal team) preferably specialised in
hernia surgery, to diagnose a possible parastomal hernia. At
12 months patients for whom no clinical parastomal hernia-
tion has been found will undergo a CT examination of the
abdomen (wall), performed in prone position [25], which
also will be part of the routine 12 months follow-up by ab-
domen CT for colorectal cancer patients. A study-specific
standardised referral to abdomen CT is used, and although
the study is not blinded, no information as to type of stoma
construction is included. All radiologic departments use a
specific protocol for this part of the abdomen CT.
Stoma height, diameter, colour, skin irritation and ban-
daging problems are documented by nurses specialised
in stoma care during hospitalisation and at 4-6 weeks,
6 months and 12 months and are registered in a CRF.
Quality of life
All patients are asked to fill out questionnaires preopera-
tively, at 6 months and at 12 months after discharge from
the hospital. The questionnaire has been constructed
using previously used questions [28] that have been devel-
oped through a process of in-depth qualitative interviews
and content validated by an expert panel consisting of
colorectal surgeons, stoma care nurses and nurses specia-
lised in surgery. The questionnaire was face-to-face vali-
dated by patients with a surgical procedure including a
colostomy as well as patients with an existing colostomy
using the validation methods described previously for a
questionnaire for prostate cancer patients (26).
Health economic evaluation
A health economic analysis will be performed based on
the information collected in the CRF together with in-
formation from the hospital registries, based on the
model presented by Bjöholt et al. [29]. The model will
be used in combination with sensitivity calculations.
Data collecting and monitoring
An operative CRF including reasons for surgery, planned
operation and patient data, together with measurements
from the surgical procedure is filled in for the operation
(by the surgeon). For the hospitalisation period a nurse
at the ward will complete a CRF, and for each follow-up
visit a surgeon and a nurse will complete a CRF.
The postoperative questionnaires will be given to the pa-
tients by the stoma therapist. All data will be kept within
University of Gothenburg and Sahlgrenska University
Hospital systems using inherent security systems. A logis-
tic database with complete patient ID will be used and
kept within a separate IT system from the result database
with all study information. Security measures will include
one to maximum two users of this database, with unique
usernames and personal login, as well as automatic
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are returned to the trial coordinating centre, SSORG, at
Sahlgrenska University Hospital. The finalised database
based on trial number and without patient ID, will be kept
within another IT system than the logistic database.
Statistical analysis
The Swedish trial on the effect of prophylactic net place-
ment has reported 50% incidence of parastomal hernia
without mesh [14]. Our own data on abdominoperineal
excision from Sahlgrenska University Hospital indicate
an incidence of 25% [28]. The power calculation based
on available information has used the hypothesis that
the cruciate incisional stoma formation, performed as
described here, should result in parastomal hernia inci-
dence of 30% and the circular incision or prophylactic
mesh reinforcement could reduce this incidence to 10%
each. An 80% power and a 5% level of significance with
a two-sided alternative hypothesis would require 62 pa-
tients per group using a chi-square test. Expecting 20%
drop-outs, 80 patients will be recruited in each group.
The primary analysis will be based on the full analysis
set. This analysis set is designed to be consistent with rec-
ommendations set forth in International Conference on
Harmonisation (ICH) guidance document E9: Statistical
Principles for Clinical Trials, and is intended to adhere as
closely as practically possible to the intention-to-treat
(ITT) principle. The full analysis set will consist of all ran-
domised patients who had surgery and who contributed
with any follow-up data.
Patients will be analysed according to randomised pro-
cedure. A sensitivity analysis evaluating the actual pro-
cedure will be made for the most important outcomes.
All hypothesis testing will be conducted using two-sided
tests, and P values ≤ 0.05 after rounding will be considered
statistically significant. A pair-wise comparison between
the experimental arms and the control arm will be per-
formed and the significance level will be corrected using
the Bonferroni-Holm method. Event-type variables (yes or
no) will be compared between randomised procedures
using chi-square tests, and relative risks and risk differ-
ences will be estimated. Where appropriate, the time to
event will be described using Kaplan-Meier plots. The
number of events of a certain type (for example, number
of complications or re-operations) will be analysed using
Poisson regression with randomised procedure as a factor
and time under observation as an offset variable.
Total length of hospital stay will be compared between
groups using Wilcoxon’s rank-sum test. Sub-group ana-
lyses specifically looking at the following groups of pa-
tients will be performed:
a) BMI >30 kg/m2
b) ImmunosuppressionSensitivity analyses will be performed for the primary
variable and selected secondary variables, as deemed appro-
priate, where groups are compared pair-wise utilising only
data from centres where both treatments were allocated.
Exploratory analyses (such as logistic regression) may
be performed to investigate the influence of background
factors (patient characteristics, perioperative factors) on
outcomes.
Participating hospitals
The study will recruit patients from hospitals in Denmark
and Sweden.
Approvals and registration
The trial has been approved by the Swedish Ethical
Committee (EPN/Göteborg Dnr 547-12) and the Swedish
radiotherapy protection committee (Dnr 12-38). It has
been approved by the Danish ethics committee (Protocol
H-4-2013-061), and by the Danish Data Protection Agency
(no. HEH-2013-049, I-Suite no:02418). The study was reg-
istered at www.clinicaltrials.gov (NCT NCT01694238)
prior to inclusion of the first patient.
Discussion
Parastomal hernia is a common complication after stoma
creation (12, 13). There are several randomised trials that
have tried to evaluate a reduction of the occurence of
parastomal hernia with placement of a prophylactic mesh
[13,14,30]. However, the use of a prophylactic measure
must be evaluated in relation to health-related QoL as
well as health economy. It is important to have enough
power to thoroughly evaluate possible complications and
side effects. A recent health technology assessment at
Sahlgrenska University Hospital concluded that mesh
probably is beneficial in regard to parastomal hernia for-
mation, but that further studies are required [31]. At
present there are at least six other randomised trials inves-
tigating the importance of a mesh for prevention of para-
stomal hernia, including one Norweigan study [32] with
60 patients, one Danish study that was stopped before in-
cluding the planned 198 patients [33] and one Swedish
study with 300 patients [34]. Sixty patients are randomised
to mesh/no mesh in a Spanish study [35], another Spanish
study is randomising 32 patients to intraperitoneal mesh
placement [36] and 200 patients are randomised in a
French study [37]. In addition there is a Dutch study, with
150 patients [38].
Our study will provide additional information comple-
menting these studies through the evaluation of the sur-
gical technique without a mesh in the control arm and
in the interventional arms. Furthermore, the QoL and
health economic evaluation will enable improved decision-
making regarding prophylactic measures against parasto-
mal herniation.
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The trial is ongoing and recruiting patients at centres in
both Denmark and Sweden. Hospitals interested in par-
ticipating are welcome to contact the corresponding
author.
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